Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Johnson & Johnson (NYSE:JNJ)

136.57
Delayed Data
As of 4:01pm ET
 +1.36 / +1.01%
Today’s Change
109.32
Today|||52-Week Range
137.08
+18.54%
Year-to-Date
Q2 Earnings Scorecard and Stock Reports for JNJ, Coke & Honeywell
12:39pm / Zacks.com - Paid Partner Content
Company News for July 19, 2017
Jul 19 / Zacks.com - Paid Partner Content
Dubuque Bank & Trust Co Buys Visa Inc, Tri Continental Corporation, Rockwell Collins ...
10:39am / GuruFocus News - Paid Partner Content
Gilead's HCV Portfolio Receives a Boost With Vosevi Approval
Jul 19 / Zacks.com - Paid Partner Content
Yacktman Focused Fund Buys Cognizant and Infosys, Sells Out of Unilever
Jul 19 / GuruFocus News - Paid Partner Content
Nasdaq Reaches New High
Jul 18 / GuruFocus News - Paid Partner Content
Roanoke Asset Management Corp Buys Emerson Electric Co, Eli Lilly and Co, Fortive Cor...
Jul 19 / GuruFocus News - Paid Partner Content
Johnson & Johnson Signals It Could Make Additional Divestitures
Jul 18 / TheStreet.com - Paid Partner Content
J&J Brightens Outlook: Healthcare ETFs in Focus
Jul 19 / Zacks.com - Paid Partner Content
Marathon Asset Management Llp Buys Oracle Corp, Yum China Holdings Inc, Johnson & Joh...
Jul 18 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close135.21
Today’s open135.73
Day’s range135.62 - 137.08
Volume5,515,456
Average volume (3 months)5,895,080
Market cap$364.2B
Dividend yield2.46%
Data as of 4:01pm ET, 07/20/2017

Growth & Valuation

Earnings growth (last year)+8.21%
Earnings growth (this year)+6.55%
Earnings growth (next 5 years)+5.90%
Revenue growth (last year)+2.47%
P/E ratio23.0
Price/Sales4.47
Price/Book5.20

Competitors

 Today’s
change
Today’s
% change
NVSNovartis+0.39+0.46%
PFEPfizer-0.08-0.24%
MRKMerck+0.32+0.51%
SNYSanofi+1.25+2.67%
Data as of 4:02pm ET, 07/20/2017

Financials

Next reporting dateOctober 17, 2017
EPS forecast (this quarter)$1.78
Annual revenue (last year)$71.9B
Annual profit (last year)$16.5B
Net profit margin22.99%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Alex Gorsky
Chief Financial Officer &
Vice President
Dominic J. Caruso
Corporate headquarters
New Brunswick, New Jersey

Forecasts